Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin PK in Caucasian and Asian Morbid Obese Patients
NCT02215174Phase 1Terminated
- Sponsor
- University of California, San Francisco
- Start
- Feb 2015
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 1, open-label trial of rosuvastatin in hypercholesterolemia (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Area-under-the-concentration curve of rosuvastatin at 48 hours. Started Feb 2015; status: terminated.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02215174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02215174.